Yannik Régimbald-Dumas

Yannik Régimbald-Dumas is a Principal Scientist and Group Leader at Jnana Therapeutics, with experience dating back to September 2019. Previously, Yannik served as a Senior Scientist and a Research Fellow at Harvard Medical School from April 2011 to March 2019, focusing on research areas including CRISPR/Cas9 mouse engineering, colorectal cancer, intestinal stem cells, organoid culture, embryonic development, and Wnt signaling. Yannik's academic background includes a PhD in Pharmacology from Université de Sherbrooke, where biomedical research, cell signaling, and calcium signaling were key areas of study. Additional educational qualifications comprise a degree in Biotechnology and Health Sciences from Université de Sherbrooke and a research fellowship in Biochemistry and Molecular Biology from Harvard Medical School.